SIA
DALS

Schechter Investment Advisors’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Schechter Investment Advisors’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-227,937
Closed -$2.34M – 723
2023
Q2 		$2.34M Sell
227,937
-6,251
-3% -$63.8K 0.21% 91
2023
Q1 		$2.37M Buy
234,188
+103,603
+79% +$1.04M 0.22% 89
2022
Q4 		$1.29M Buy
+130,585
New +$1.29M 0.12% 217

Schechter Investment Advisors's DALS Position: Q3 2023 in Review

Schechter Investment Advisors sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 227,937 shares — an estimated $2.34M sold.

Schechter Investment Advisors first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $2.37M in Q1 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Schechter Investment Advisors reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Schechter Investment Advisors sold 227,937 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $2.34M.
  • Schechter Investment Advisors first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 3 quarters.
  • Schechter Investment Advisors's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $2.37M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Schechter Investment Advisors's 13F filing for Q3 2023, filed 6 Nov 2023.